NEVRO CORP·4

Jun 9, 4:36 PM ET

DEMANE MICHAEL F 4

4 · NEVRO CORP · Filed Jun 9, 2023

Insider Transaction Report

Form 4
Period: 2023-06-07
DEMANE MICHAEL F
DirectorChief Executive Officer
Transactions
  • Gift

    Common Stock

    2023-06-0780,00027,772 total
Holdings
  • Common Stock

    (indirect: See footnote)
    131,225
  • Common Stock

    (indirect: See footnote)
    18,266
  • Common Stock

    (indirect: See footnote)
    122,541
  • Common Stock

    (indirect: See footnote)
    164,344
Footnotes (6)
  • [F1]Includes 6,754 restricted stock units.
  • [F2]Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2012 Irrevocable Trust U/A/D July 26, 2012.
  • [F3]Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2017 Family SLAT Trust U/A/D May 22, 2017 (the "SLAT Trust").
  • [F4]Shares held by Michael F. DeMane & Catherine Q. DeMane, Trustees, Michael F. DeMane Revocable Trust U/A 10/07/2011 (the "2011 Trust").
  • [F5]Shares held by Michael F. DeMane, Trustee, Michael F. DeMane 2021 Retained Annuity Trust U/A 08/13/2021.
  • [F6]Reflects the transfer of 40,000 directly held shares to each of the SLAT Trust and the 2011 Trust on June 7, 2023.

Documents

1 file
  • 4
    form4.xmlPrimary